Seres Therapeutics Change in Payables and Accrued Expense (Quarterly) Trends

Seres Therapeutics, Inc. (MCRB)

8.65 +0.49 (+6.00%) USD | NASDAQ | Feb 24, 16:00

8.68 +0.03 (+0.35%) After-Hours: 20:00

View Change in Payables and Accrued Expense (Quarterly) for MCRB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Change in Payables and Accrued Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Change in Payables and Accrued Expense (Quarterly) Benchmarks

Start Trial

Altimmune, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	Upgrade